Change of https://www.gov.uk/government/publications/pcv-13-valent-adsorbed-patient-group-direction-pgd-template

Change description : 2026-01-05 09:30:00: Added version 7 – see page 3 for change history. [Guidance and regulation]

Showing diff : 2025-06-03 13:05:09.397462507 +00:00..2026-01-05 09:31:34.678267149 +00:00

Guidance

PCV (13-valent or 15-valent, adsorbed): patient group direction (PGD) template

PGD template to support the national pneumococcal polysaccharide conjugate vaccine (13-valent or 15-valent, adsorbed) (PCV) vaccination programme.

From:
UK Health Security Agency
Published
4 February 2016
Last updated
35 JuneJanuary 20252026 — See all updates

Applies to England

Documents

PCV (13-valent or 15-valent, adsorbed): patient group direction (PGD) template

Ref: UKHSA gateway number GOV-18485GOV-19753

MS Word Document, 197196 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template is to support the administration of pneumococcal polysaccharide conjugate vaccine (13-valent or 15-valent, adsorbed) (PCV13 or PCV15) (PCV) to individuals from 1216 weeks to under 2 years of age in accordance with the national immunisation programme.programme for active immunisation against pneumococcal disease.

The PCV routine PGD version 6.07.0 is valid from 15 JulyJanuary 20252026 to 315 MayJanuary 2027.2029.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Updates to this page

Published 4 February 2016
Last updated 35 JuneJanuary 20252026 + show all updates

  2. Added version 6 - see page 3 for change history.

Sign up for emails or print this page

Update history

2026-01-05 09:30
Added version 7 – see page 3 for change history.

2025-06-03 14:00
Added version 6 – see page 3 for change history.

2024-01-30 10:30
Added version 5.00 – see page 3 for change history.

2022-02-17 14:40
Added version 04.00 – see change history on page 2.